Avicanna Inc. (OTCMKTS:AVCNF – Get Free Report) saw a significant decline in short interest during the month of September. As of September 30th, there was short interest totaling 88,700 shares, a decline of 57.9% from the September 15th total of 210,600 shares. Based on an average trading volume of 104,309 shares, the short-interest ratio is presently 0.9 days.
Avicanna Price Performance
Avicanna stock opened at $0.08 on Wednesday. The business’s fifty day moving average is $0.08 and its two-hundred day moving average is $0.09. Avicanna has a 52 week low of $0.06 and a 52 week high of $0.21.
Avicanna Company Profile
Avicanna Inc is a biopharmaceutical company focused on the development, manufacture and commercialization of cannabinoid-based products and therapies. The company applies pharmaceutical research and formulation expertise to create products designed for medical, wellness and consumer applications.
Avicanna’s activities include cannabinoid research, cultivation and processing support, product formulation, clinical development and commercialization. Its offerings have included medical cannabis products, pharmaceutical preparations and cannabinoid-based topical and wellness products, including products marketed under the RHO Phyto brand in Canada.
The company has historically maintained operations and commercial relationships in Canada and Colombia, supporting its research, cultivation, manufacturing and distribution activities.
See Also
- Five stocks we like better than Avicanna
- A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?
- Could T-Mobile’s Satellite Competition Fears Create a Buying Opportunity?
- Surgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow Runway
- Tesla’s Robotaxi Lands in Paris—But Europe’s Real Fight Is Over Cheap EVs
Receive News & Ratings for Avicanna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avicanna and related companies with MarketBeat.com's FREE daily email newsletter.
